The clinical benefit of hyperthermia in pancreatic cancer: a systematic review-Reference-Cited by-同舟云学术

The clinical benefit of hyperthermia in pancreatic cancer: a systematic review

Published:2017-11-23 Issue:7 Volume:34 Page:969-979
ISSN:0265-6736
Container-title:International Journal of Hyperthermia
language:en
Short-container-title:International Journal of Hyperthermia

Author:

van der Horst Astrid¹,Versteijne Eva¹,Besselink Marc G. H.²,Daams Joost G.³,Bulle Esther B.¹,Bijlsma Maarten F.⁴,Wilmink Johanna W.⁵,van Delden Otto M.⁶,van Hooft Jeanin E.⁷,Franken Nicolaas A. P.⁴^ORCID,van Laarhoven Hanneke W. M.⁵,Crezee Johannes¹^ORCID,van Tienhoven Geertjan¹

Affiliation:

1. Department of Radiation Oncology and Hyperthermia, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands;

2. Department of Surgery, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands;

3. Medical Library, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands;

4. Laboratory for Experimental Oncology and Radiobiology (LEXOR), Center for Experimental and Molecular Medicine (CEMM), Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands;

5. Department of Medical Oncology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands;

6. Department of Radiology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands;

7. Department of Gastroenterology and Hepatology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands

Publisher

Informa UK Limited

Subject

Cancer Research,Physiology (medical),Physiology

Link

https://www.tandfonline.com/doi/pdf/10.1080/02656736.2017.1401126

Reference74 articles.

1. Netherlands Cancer Registry: [Figures about Cancer] (in Dutch). Available from: http://www.cijfersoverkanker.nl/selecties/Dataset_1/img59b5566ddcaf0 [last accessed 14 Sep 2017].

2. SEER database. Available from: https://seer.cancer.gov/statfacts/html/pancreas.html [last accessed 9 Sep 2017].

3. Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial

4. Adjuvant Chemotherapy With Gemcitabine vs Observation in Patients Undergoing Curative-Intent Resection of Pancreatic Cancer

5. Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel therapeutic strategies in pancreatic cancer: moving beyond cytotoxic chemotherapy;Expert Review of Anticancer Therapy;2023-10-19

2. The future opportunities and remaining challenges in the application of nanoparticle‐mediated hyperthermia combined with chemo‐radiotherapy in cancer;WIREs Nanomedicine and Nanobiotechnology;2023-10

3. Gemcitabine and rapamycin-loaded mixed polymeric thermogel for metastatic pancreatic cancer therapy;Journal of Controlled Release;2023-08

4. Triple modal treatment comprising with proton beam radiation, hyperthermia, and gemcitabine/nab-paclitaxel for locally advanced pancreatic cancer: a phase I/II study protocol (TT-LAP trial);BMC Cancer;2023-07-04

5. Hyperthermia combined with chemotherapy vs chemotherapy in patients with advanced pancreatic cancer: A multicenter retrospective observational comparative study;World Journal of Clinical Oncology;2023-06-24